Anupam Talapatra

Anupam Talapatra is a seasoned professional in regulatory affairs and quality assurance, currently serving as the Global Director of Regulatory Affairs (Precision Medicine) at Gilead Sciences since May 2023. Talapatra has extensive experience across various organizations, including key roles at ARK Diagnostics, Freenome, and HCL Technologies, where responsibilities encompassed regulatory submissions, compliance with international regulations, and quality management systems. With a solid background in developing strategies for IVD and Companion Diagnostics, Talapatra has successfully led initiatives for clinical development and drug approvals, maintained adherence to regulatory norms, and fostered training programs in regulatory and quality aspects of precision medicine. Educational qualifications include a degree from the University of California, Berkeley, supplemented by professional certifications such as RAC, PMP, and CQA.